What happens when first-line treatment for Melanoma stops working

When First-Line Melanoma Treatment Stops Working

This is an important question, and I'm glad you're thinking through what happens if initial treatment doesn't work as hoped. Let me explain how oncologists approach this situation based on current medical guidelines.

How Doctors Assess Treatment Response

According to the NCCN Guidelines for Patients: Melanoma (2025), doctors typically evaluate how well your treatment is working through:

• Clinical exams - Physical examination of your skin and lymph nodes
• Imaging tests - CT scans, PET scans, or other imaging to check for cancer growth
• Biopsies - Sometimes a tissue sample to confirm what's happening

These assessments help determine whether the cancer is:

• Responding well (shrinking or stable)
• Showing residual disease (some cancer remaining)
• Progressing (growing despite treatment)

What Happens Next: The Treatment Pathway

When first-line treatment isn't working effectively, your oncologist will typically move to one of several options depending on your specific situation:

For Resectable Disease (cancer that can be surgically removed):

According to NCCN Guidelines, options may include:

• Surgery to remove remaining tumors with clear margins
• Different systemic therapy (immunotherapy or targeted therapy)
• Combination approaches - surgery plus additional treatments
• T-VEC (talimogene laherparepvec) - an intralesional therapy that uses a modified virus to kill cancer cells directly

For Unresectable/Borderline Resectable Disease (cancer that cannot be completely removed surgically):

The NCCN Guidelines recommend:

• Switching to different systemic therapy - This is the preferred approach
• Intralesional injections like T-VEC
• Radiation therapy to target specific areas
• Regional chemotherapy (isolated limb infusion/perfusion or ILI/ILP) - if melanoma is confined to an arm or leg
• Palliative care - focused on symptom relief and quality of life

Key Treatment Options Available

Immunotherapy Options:

• Nivolumab (Opdivo)
• Pembrolizumab (Keytruda)
• Ipilimumab (combination checkpoint inhibitor)

Targeted Therapy (if you have a BRAF V600 mutation):

• Dabrafenib/trametinib combination

Why the switch matters: Different treatments work through different mechanisms. If your cancer cells have adapted to resist one approach, a different treatment strategy may be more effective.

Important Questions to Ask Your Oncologist

When discussing what happens if your current treatment isn't working, consider asking:

1. "How will you determine if my treatment is working, and how often will you check?"
2. "If my current treatment stops working, what are my next treatment options?"
3. "Do I have any genetic mutations (like BRAF) that would make me eligible for targeted therapy?"
4. "Are there clinical trials available for my stage and type of melanoma?"
5. "What is the goal of the next treatment - to shrink the cancer, control it, or manage symptoms?"

The Bottom Line

According to the NCCN Guidelines, melanoma treatment is not a one-size-fits-all approach. If your first treatment isn't working, multiple evidence-based options exist. Your oncologist will reassess your situation and adjust your treatment plan based on:

• Whether your cancer can be surgically removed
• Your genetic test results (BRAF status)
• How your cancer is responding
• Your overall health and treatment goals

The key is staying in close communication with your care team and being prepared to discuss next steps if needed.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.